Atlas Trials

Preventive Effects of Aspirin as Adjuvant Therapy in Patients With Locally Advanced Renal Cell Carcinoma

Clinical trial NCT03734614 · UNKNOWN

Trial details

NCT number
NCT03734614
Sponsor
RenJi Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Aspirin as Adjuvant Therapy in Patients With Surgically Treated High Risk Renal Cell Carcinoma
Start date
2018-10-08
Primary completion
2024-10-01
Enrollment
260

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.